FY22 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- FDABAA-22-00123
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Place of performance
- Silver Spring, Maryland 20993, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Food and Drug Administration seeks research and development proposals through this Broad Agency Announcement to advance regulatory science in nine areas of interest. Proposals are sought to develop new tools, standards, and approaches supporting safety, efficacy, and quality evaluations of FDA-regulated products. Proposals will undergo a two-tiered evaluation, with multiple awards anticipated subject to proposal quality and available funding levels. Proposals are due January 21, 2022 for consideration in fiscal year 2022.
There is no set-aside designation. Proposals are not limited to PSC code AJ11 and may involve private, academic, or government entities. Research and development activities will take place in Silver Spring, Maryland, with annual renewals and amendments posted to SAM.gov. Award amounts will depend on proposal quality and available funding levels. The Broad Agency Announcement does not restrict proposals to current contractors and remains open until further notice for consideration in fiscal year 2022 and beyond.
Notice text
2 versions
Update #2 · Latest ·
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
*This announcement is a renewal of the prior-year FY21 announcement (FDABAA-21-00123) and will remain open until further notice. This announcement is renewed on an annual basis.
Update #1 ·
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
*This announcement is a renewal of the prior-year FY21 announcement (FDABAA-21-00123) and will remain open until further notice. This announcement is renewed on an annual basis.
Files
| File | Type | Posted |
|---|---|---|
| 2021.11.06 - FY22 BAA 111021 version 2.pdf | ||
| 2021.11.06 - FY22 BAA 111021.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| FY22 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science | Award Notice | |
| This notice | Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity